Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Woori IO is developing a noninvasive glucose monitoring device using near-infrared spectroscopy (NIRS), aiming to eliminate the need for finger pricks and sensors in diabetes management. The company has completed proof-of-concept studies validating accuracy and is preparing for a larger confirmatory trial for regulatory approval in South Korea. The technology is positioned for wearable integration, such as smartwatches, and has been selected for Samsung Electronics' C-Lab Outside program. No truly noninvasive glucose monitor has yet received global regulatory approval; Woori IO is among the few with both a working prototype and a regulatory path.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Woori IO.